While GRP78 is established to be critical for solid tumor progression and drug resistance [5], [15], [55], [64]–[69], the role of GRP78 and GRP78va in hematological cancers remains to be determined. The gene discussed is HSPA5; the disease is hematopoietic and lymphoid cell neoplasm.